Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
International Journal of Medicinal Mushrooms
Импакт фактор: 1.423 5-летний Импакт фактор: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Печать: 1521-9437
ISSN Онлайн: 1940-4344

Том 21, 2019 Том 20, 2018 Том 19, 2017 Том 18, 2016 Том 17, 2015 Том 16, 2014 Том 15, 2013 Том 14, 2012 Том 13, 2011 Том 12, 2010 Том 11, 2009 Том 10, 2008 Том 9, 2007 Том 8, 2006 Том 7, 2005 Том 6, 2004 Том 5, 2003 Том 4, 2002 Том 3, 2001 Том 2, 2000 Том 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/InterJMedicMush.v5.i3.20
12 pages

Antibacterial and Antiviral Value of the Genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): A Review

Yihuai Gao
Institute of Food, Nutrition and Human Health, Massey University; Landcare Research, Private Bag 92170, Auckland, New Zealand
Shufeng Zhou
Division of Pharmacy, School of Life Sciences, Faculty of Science, Queensland University of Technology, Australia; Department of Pharmacy, Faculty of Science, National University of Singapore; University of South Florida FL 33612, USA
Min Huang
Department of Clinical Pharmacology, School of Pharmaceutical Sciences, Zhongshan (Sun Yat-Sen) University, Guangzhou, R.P. China
Anlong Xu
Biopharmaceutical Development Center, Department of Biochemistry, School of Life Sciences, Sun Yat-sen University, Guangzhou, The People’s Republic of China

Краткое описание

Various effective synthetic antibacterial and antiviral agents have been developed, but drug resistance and toxicity may occur. Herbal medicines may represent a safe and useful approach for the treatment of infectious diseases. Ganoderma lucidum and other Ganoderma species, alone or more often in combination with chemotherapeutic agents, have been used to treat chronic infectious diseases such as chronic hepatitis and bronchitis, although there is limited clinical data available. Data from in vitro and in vivo animal studies indicate that G. lucidum and other Ganoderma species exhibit a broad spectrum of antibacterial and antiviral activities. A recent randomized placebo-controlled clinical study indicates that treatment with G. lucidum polysaccharides at 5400 mg/day for 12 weeks caused inhibitory effects on hepatitis B virus (HBV) replication, as indicated by the decreased serum HBV DNA and hepatitis B e antigen (HBeAg) levels. It appears that both polysaccharides and triterpenoids are the major antiviral constituents of Ganoderma species, while the polysaccharides play a more important role for its antibacterial activity. There appears to be a structure–activity relationship for triterpenoid-mediated antiviral effect. The mechanisms for the antibacterial and antiviral activities of G. lucidum and other Ganoderma species are largely undefined. Ganoderma constituents (e.g., polysaccharides and triterpenoids) may inhibit viral replication by interfering with their adsorption, virus-hepatocyte fusion and endocytosis, and viral integration, assembly, and release. Currently available data suggest that G. lucidum and some other Ganoderma species may play an adjunct role for the management of various infectious diseases, and further experimental and clinical studies are needed.

Articles with similar content:

Hepatoprotective Activity and the Mechanisms of Action of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetideae) (Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Yihuai Gao, Min Huang, Zhi-Bin Lin, Shufeng Zhou
Genes Responsible for Quantitative Regulation of Antibody Production
Critical Reviews™ in Immunology, Vol.16, 1996, issue 3
Anne Puel , Denise Mouton
The Efficacy and Toxicity of Using the Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), and Its Products in Chemotherapy (Review)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 10
Martina Cizmarikova
Chemopreventive and Tumoricidal Properties of Ling Zhi Mushroom Ganoderma lucidum (W. Curt.:Fr.) Lloyd (Aphyllophoromycetideae). Part I. Preclinical and Clinical Studies (Review)
International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 2
He Gao, Jin Lan, Yihuai Gao, Wenbo Tank, Shufeng Zhou
Review of Biological and Pharmacological Activities of the Endemic Taiwanese Bitter Medicinal Mushroom, Antrodia camphorata (M. Zang et C. H. Su) Sh. H. Wu et al. (Higher Basidiomycetes)
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 3
Yi-Yi Wong, Patrick Ying-Kit Yue, Carman Ka-Man Law, Kelvin Sze-Yin Leung, Tony Yuk-Kit Chan, Yeuk-Ki Tsoi